Skip to content
Neoadjuvant Therapy: What is it and When is it Used? episode artwork

Feb 18, 2019 6 min

Neoadjuvant Therapy: What is it and When is it Used?

from Breast Cancer Trials Hosted by Breast Cancer Trials

Neoadjuvant Therapy: What is it and When is it Used? Neoadjuvant therapy refers to treatment before surgery, and it aims to shrink the breast cancer in size to increase the chance of breast-conserving surgery and to monitor the effect of treatment on the tumour. In this podcast, Professor Prue Francis, Former Chair of the Breast Cancer Trials Scientific Advisory Committee, explains the potential benefits of neoadjuvant therapy and why it's been increasingly used in breast cancer research. Tune in for a deep dive into this important research. Like this episode? ⁠⁠Follow Breast Cancer Trials on Social Media: Instagram:⁠ ⁠⁠@breastcancertrials⁠⁠⁠ Facebook:⁠ ⁠⁠Breast Cancer Trials⁠⁠⁠ LinkedIn: ⁠⁠⁠Breast Cancer Trials⁠⁠⁠ X: ⁠⁠⁠@BCTrialsANZ⁠⁠⁠ Guest: Medical Oncologist, Professor Prue Francis. Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about neoadjuvant therapy. Find out more: www.breastcancertrials.org.au

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Neoadjuvant Therapy: What is it and When is it Used?

0:00 6:54

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Breast Cancer Trials?

This episode is 6 minutes long.

When was this Breast Cancer Trials episode published?

This episode was published on February 18, 2019.

Can I download this Breast Cancer Trials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.